Aviana Healthcare (AVAH) Q3 2024: Preferred Payer Agreements Climb to 21, Driving Margin Expansion
Aviana Healthcare’s third quarter showed clear acceleration in its preferred payer strategy, with payer agreements up 50% year-to-date and margin expansion across all segments. Labor market headwinds are easing, as targeted rate increases in key states translate directly into hiring and volume gains. With the business model now fully aligned to higher-value payers and a disciplined approach to cost and capital, Aviana is positioned to sustain profitable growth into 2025 even as reimbursement risk and state-level negotiations remain ongoing.
Summary
- Preferred Payer Penetration Deepens: Aviana’s strategic pivot to preferred payer agreements is now driving both volume and margin upside.
- Labor Constraints Easing: Targeted wage investments in Georgia and Massachusetts are unlocking caregiver supply and reducing hospital backlogs.
- Margin Expansion Holds: Cost discipline and rate-driven pricing power are supporting sustainable profitability across core segments.
Business Overview
Aviana Healthcare Holdings is a leading provider of home and community-based care, generating revenue primarily from three segments: Private Duty Services (PDS), Home Health and Hospice, and Medical Solutions. The company’s business model centers on delivering skilled nursing, therapy, and nutrition services to medically complex patients, with a payer mix spanning government programs, managed care organizations (MCOs), and private insurers. Revenue is driven by hours of care delivered, episodic admissions, and unique patients served, with a growing emphasis on preferred payer agreements to secure higher reimbursement rates and support wage investments.
Performance Analysis
Aviana posted consolidated revenue growth of 6.5% year-over-year, with all three operating divisions contributing positively. Private Duty Services, the largest segment, delivered a 6.4% revenue increase on 3.8% higher care hours, as recent state-level rate wins in Georgia and Massachusetts flowed directly into both pricing and hiring. Medical Solutions outpaced the group with a 12.6% top-line gain, while Home Health and Hospice grew 2.2%, supported by a 1% rise in episodic volume and a payer mix now 76% episodic.
Gross margin expansion was a standout, particularly in Home Health and Hospice, where margins climbed 6% year-over-year to 53.9%. PDS gross margin improved to 26.8%, and Medical Solutions delivered 45.6% (noted as temporarily elevated due to timing items, with normalization expected). Adjusted EBITDA rose 32.2% year-over-year, reflecting the dual impact of improved payer rates and sustained cost reduction initiatives.
- Volume Recovery Driven by Rate Pass-Through: Increases in state reimbursement, notably in Georgia, directly translated into higher caregiver hiring and case fill rates.
- Margin Gains Across Segments: Cost containment and payer mix optimization drove margin improvement, with Home Health and Hospice now exceeding targeted profitability levels.
- Free Cash Flow Turns Positive: Q3 delivered strong operating and free cash flow, aided by working capital discipline and robust collections from payer partners.
Liquidity remains ample, with $285 million in available funds and no material debt maturities until 2028, supporting continued investment in growth and M&A as the company re-engages in strategic acquisitions for 2025.
Executive Commentary
"By focusing our clinical capacity on our preferred payers, we achieved solid year-over-year growth in revenue and adjusted EBITDA. We also experienced improvement in our caregiver hiring and retention trends by aligning our efforts to those payers willing to engage with us on enhanced reimbursement rates and value-based agreements."
Jeff Shainer, Chief Executive Officer
"We continue to fight through a difficult labor environment while keeping our patients' care at the center of everything we do. It's clear to us that shifting caregiver capacity to those preferred payers who value our partnership is the path forward at Aviana."
Matt Bockhalter, Chief Financial Officer
Strategic Positioning
1. Preferred Payer Model Scaling Across Segments
Aviana’s preferred payer strategy, which prioritizes agreements with payers offering higher reimbursement and value-based contracts, is now the central driver of both growth and margin improvement. In PDS, the number of preferred payer agreements rose from 14 to 21 year-to-date, with a robust pipeline set to exceed the 2024 goal. This model is now fully embedded in Home Health and Hospice, where the episodic payer mix is consistently above 70%, and is being rolled out in Medical Solutions, with full realization targeted for 2025.
2. Legislative Advocacy and Rate Negotiation as Growth Engines
State-level advocacy remains a core competency, with 12 private duty services state rate increases secured year-to-date. Georgia and Massachusetts are cited as case studies for successful wage pass-through and rapid hiring gains, while California remains a challenging but high-potential market as legislative efforts continue. The company’s ability to translate legislative wins into immediate operational and financial upside is a key differentiator.
3. Cost Discipline and Operational Leverage
After seven quarters of targeted cost reduction, Aviana has largely completed restructuring in Home Health, Hospice, and PDS, shifting focus to Medical Solutions for further efficiency gains. Ongoing reinvestment in automation and technology is expected to sustain margin improvements and support scalable growth.
4. Capital Structure and M&A Readiness
With $285 million in liquidity and a hedged debt portfolio, Aviana is positioned to re-enter the M&A market in 2025, targeting bolt-on acquisitions in PDS and Home Health and Hospice. Management signaled that inorganic growth will be a renewed priority as the transformation phase concludes.
5. Labor Market Dynamics and Wage Pass-Through
Improved reimbursement rates are enabling Aviana to invest directly in caregiver wages, unlocking supply and reducing patient backlogs, particularly in states with recent legislative wins. This wage pass-through is central to the company’s ability to scale care delivery and meet demand.
Key Considerations
Aviana’s Q3 marks a strategic inflection point, with preferred payer penetration now supporting both top-line growth and margin expansion. Investors should monitor the sustainability of these gains as the company faces ongoing reimbursement negotiations and labor market normalization.
Key Considerations:
- Preferred Payer Expansion Momentum: The rapid increase in preferred payer agreements is directly tied to both volume and margin gains, but continued expansion is needed to offset reimbursement risk from non-preferred payers.
- Legislative Wins Drive Operational Leverage: Successful rate negotiations in key states accelerate hiring and volume, but California remains a wildcard with significant upside or downside depending on legislative outcomes.
- Margin Normalization in Medical Solutions: Q3 margins benefited from timing, with normalization expected in Q4 and beyond; investors should track the pace of preferred payer adoption in this segment.
- Capital Deployment for Growth: Ample liquidity and no near-term maturities set the stage for renewed M&A activity, with management signaling a pivot from transformation to growth mode in 2025.
Risks
State-level reimbursement remains a structural risk, especially in large markets like California where legislative outcomes are uncertain. Labor supply, while improving, could tighten again if wage investments stall or if inflationary pressures return. Margin gains in Medical Solutions are subject to normalization, and further cost savings may be harder to achieve outside of targeted automation and technology upgrades. The company’s model is also sensitive to regulatory changes and shifts in payer mix.
Forward Outlook
For Q4, Aviana guided to:
- Revenue normalization following Q3’s outperformance, with some impact from hurricane-related disruptions in the Southeast.
- Margins expected to moderate as Medical Solutions gross margin returns to the 43-44% range.
For full-year 2024, management raised guidance:
- Revenue of approximately $2 billion
- Adjusted EBITDA greater than $168 million
Leadership cited ongoing preferred payer expansion, continued legislative advocacy, and operational discipline as the primary drivers for confidence in sustaining growth into 2025.
- California remains a legislative focus, with upside potential if rate increases are secured.
- Medical Solutions will be the next segment to fully adopt the preferred payer strategy, with choppiness expected during the transition.
Takeaways
Aviana’s Q3 execution validates the preferred payer strategy as a scalable model for both growth and margin expansion. With cost initiatives largely complete and liquidity supporting renewed M&A, the company is entering a new phase of disciplined, payer-aligned growth.
- Preferred Payer Model Is Proving Out: The company’s ability to secure and operationalize higher-value payer agreements is now translating into measurable volume, hiring, and margin gains.
- Cost Structure Reset Is Largely Complete: Most efficiency gains are now embedded, with future margin improvement tied to payer mix and technology-driven productivity.
- 2025 Growth Will Depend on Legislative Success and M&A: Watch for California’s outcome and the pace of bolt-on acquisitions as key swing factors for next year.
Conclusion
Aviana’s Q3 results underscore a successful strategic transformation, with preferred payer penetration and disciplined cost management driving both growth and margin upside. With the business now positioned for both organic and inorganic expansion, investor focus should shift to legislative execution and the scaling of the preferred payer strategy in Medical Solutions.
Industry Read-Through
Aviana’s results reinforce a broader trend among home health and community-based care providers: payer mix optimization and legislative advocacy are now critical levers for both growth and profitability. The ability to secure preferred agreements and pass through wage gains is separating winners from peers still reliant on legacy reimbursement structures. Industry participants should expect continued consolidation, as capitalized players like Aviana seek to leverage scale and payer relationships to capture share in a labor-constrained environment. Regulatory risk and state-level variability remain key themes for the sector, with California’s outcome likely to set a precedent for rate negotiations nationwide.